The short answer: the evidence is much thinner than the prescribing rate suggests. Propranolol is not FDA-approved for any anxiety disorder; every use for anxiety is off-label. A 2016 systematic review of eight trials concluded that the quality of evidence was insufficient to support routine use of propranolol for any anxiety disorder. A 2024 systematic review and meta-analysis reached the same verdict, finding no evidence of benefit over placebo or over benzodiazepines, with only 179 participants across its pooled analyses. Where beta-blockers do plausibly help is narrow and specific: the physical symptoms of situational performance anxiety, taken once before the event.
That gap between how often they are prescribed and how well they are studied is the real story here.
What do beta-blockers actually do?
Propranolol blocks beta-adrenergic receptors, the docking sites for adrenaline and noradrenaline. Blocking them blunts the body's physical stress response: heart rate slows, palpitations soften, blood pressure comes down slightly, and the tremor in your hands and voice is reduced.
Notice what is missing from that list. Propranolol does not act on the mechanisms that generate worry, rumination, catastrophic thinking, or dread. It works on the output of the fear response, not the input.
That distinction predicts almost everything about where it helps and where it does not. If your problem is a shaking hand and a pounding heart during a 10-minute presentation, blunting the physical response addresses the problem you actually have. If your problem is lying awake rehearsing conversations, there is no physical symptom to blunt.
Our guide to the physical symptoms of anxiety covers how the adrenaline response produces these sensations in the first place.
What does the evidence actually show?
Two systematic reviews, eight years apart, reached the same conclusion.
Steenen and colleagues published a systematic review and meta-analysis in the Journal of Psychopharmacology in 2016. It included eight studies: four in panic disorder (n=130), two in specific phobia (n=37), one in social phobia (n=16), and one in PTSD (n=19). The authors concluded that the quality of evidence was insufficient to support routine use of propranolol in the treatment of any of the anxiety disorders.
Two features of that evidence base explain the verdict. The sample sizes are tiny, and most of the randomized trials were conducted more than thirty years ago, before modern diagnostic criteria and trial standards.
Archer and colleagues published a newer systematic review and meta-analysis in the Journal of Affective Disorders in 2024 (volume 368, pages 90-99). They identified 10 studies, of which 5 could be pooled, covering 179 participants with social phobia or panic disorder with or without agoraphobia. They found no evidence of a beneficial effect of beta-blockers compared with placebo or with benzodiazepines, with p-values of 0.54 or higher across the analyses. They noted small samples, missing data, and high or unclear risk of bias in many of the included studies, and called for a properly powered randomized trial.
Read that carefully. "No evidence of benefit" from 179 pooled participants is not the same as "proven not to work." It means the trials were too small and too old to answer the question. The honest statement is that the effectiveness of beta-blockers for anxiety disorders remains unestablished.
Where do they plausibly help?
The strongest case, and the one most clinicians have in mind when they prescribe, is situational performance anxiety: a recital, a viva, a best man's speech, a job talk, an exam presentation.
The classical work here involved musicians, and the reasoning is mechanistic rather than statistical. A violinist's problem during a performance is a measurable tremor, and beta blockade measurably reduces tremor. The same holds for a shaking voice or visible hand tremor at a lectern. Reviews of the literature support short-term use of propranolol, pindolol, or nadolol for the somatic features of anxiety tied to a specific situation.
Note how narrow that is. It is a single dose, before a discrete event, aimed at a physical symptom. It is not treatment for generalized anxiety disorder, not a daily medication, and not a substitute for therapy in social anxiety disorder, where the clinically established treatments are cognitive behavioral therapy and SSRIs.
Our guides to generalized anxiety disorder and social anxiety cover what the first-line treatments for those conditions actually are.
Who should not take propranolol?
This is where the conversation gets concrete, because propranolol has genuine contraindications that a person seeking help for anxiety may not think to mention.
- Asthma. Propranolol is non-selective, meaning it blocks beta-2 receptors in the airways as well as beta-1 receptors in the heart. Blocking beta-2 causes bronchoconstriction. The label lists bronchial asthma as a contraindication, and propranolol can provoke an asthma attack in people with bronchospastic lung disease. If you have asthma, say so before anything is prescribed. Our sister site asthma.md covers why beta-2 blockade matters for airways.
- Slow heart rate, heart block, or decompensated heart failure.
- Diabetes treated with insulin or sulfonylureas. Beta blockade masks the adrenaline warning signs of hypoglycemia, including tremor and palpitations, which removes the early warning that blood sugar is falling.
- Very low blood pressure, or a tendency to faint on standing.
Side effects to expect even when it is appropriate: fatigue, cold hands and feet, vivid dreams, dizziness, and, for some people, low mood. Propranolol should not be stopped abruptly after regular daily use, because rebound tachycardia and raised blood pressure can follow.
What has better evidence?
For anxiety disorders as diagnosed conditions, the treatments with real trial support are well established:
- Cognitive behavioral therapy, including exposure-based approaches. This has the strongest evidence base across generalized anxiety disorder, panic disorder, social anxiety disorder, and specific phobias, and its effects tend to persist after treatment ends.
- SSRIs and SNRIs, which are FDA-approved for several anxiety disorders and supported by large modern trials. They take weeks to work, which our guide to how long anxiety medication takes to work covers in detail.
- Structured behavioral measures: regular exercise, sleep regularization, and reducing caffeine, which directly amplifies the same adrenergic symptoms propranolol blocks.
If the physical symptoms are the main problem, breathing and grounding techniques are worth trying first because they carry no contraindications. See our guide to breathing techniques for anxiety attacks.
How to have the conversation with a prescriber
Bring three specifics rather than a request for a drug:
- Which symptom bothers you most. Tremor and palpitations point one way; persistent worry points another.
- Whether it is situational or continuous. A single event next month is a different problem from six months of daily dread.
- Your full medical history and medication list, especially asthma, heart conditions, diabetes, and blood pressure medications.
If a beta-blocker is offered for a one-off event, it is reasonable to ask about trying the dose on a low-stakes day first, so you learn how it affects you before it matters.
The bottom line
Beta-blockers are prescribed for anxiety far more often than the evidence supports. Two systematic reviews, in 2016 and 2024, found the trial base too small, too old, and too biased to demonstrate benefit over placebo or benzodiazepines. Propranolol has no FDA approval for any anxiety disorder.
The defensible use is narrow: a single dose before a specific performance, to blunt tremor and palpitations, in someone without asthma, bradycardia, or insulin-treated diabetes. For an anxiety disorder that persists across situations, the treatments with real evidence are CBT and SSRIs, and a beta-blocker is not a substitute for either.
Last updated: August 2026. This article is for informational purposes only and does not constitute medical advice. Do not start or stop propranolol without speaking to a prescriber, and do not stop it abruptly after regular daily use. If you are in crisis, call or text 988 (Suicide & Crisis Lifeline).